Thyroid & metabolic rate

One of 4 mechanistic pathways to 🔋 Energy & fatigue · 11 options

Thyroid hormone sets the pace of every cell. Hypothyroid fatigue comes with cold intolerance, constipation, dry skin and weight gain — and the common failure is testing TSH alone, which misses impaired T4→T3 conversion entirely.

🩸 Is this pathway actually your problem?

TSH alone is not a thyroid panel. Normal TSH with low free T3 is impaired conversion, and it is the single most common thing missed in fatigue — you need the full set to see it.

TSH (Thyroid-Stimulating Hormone)Free T3 (Triiodothyronine)Free T4 (Thyroxine)Reverse T3Thyroid Antibodies (TPO + TgAb)Selenium, BloodIodineFerritin

🦋 Thyroid — First Look covers these in one panel →

What engages this pathway

Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.

🧬 Selenium

Cofactor for the deiodinases converting T4 to active T3, and it reduces thyroid antibodies in Hashimoto's in multiple trials.

✅ Clinically validated⚠ Safety flag

🧬 Iodine

Substrate for thyroid hormone. Both deficiency and excess cause hypothyroidism, and in autoimmune thyroid disease high-dose iodine can make things considerably worse.

✅ Clinically validated⚠ Safety flag

🧬 Zinc

Required for T4→T3 conversion and for thyroid receptor function.

✅ Clinically validated

🧬 Iron

Thyroid peroxidase is an iron-dependent enzyme — low ferritin impairs hormone synthesis before it causes anemia.

✅ Clinically validated⚠ Safety flag

🧬 L-Tyrosine

The amino-acid backbone of thyroid hormone.

🧪 Theoretical / mechanistic

🧬 Thyroid Support

A cofactor blend aimed at the T4-to-T3 conversion step rather than at hormone production. Rational where conversion is the bottleneck; useless where the gland itself is failing.

🧪 Theoretical / mechanistic

💉 Thyreogen

A thyroid peptide fraction proposed to support the gland's own tissue rather than to replace its hormone. The distinction is the whole entry: if TSH and free T4 say hypothyroid, this is not the answer and levothyroxine is. Nothing outside the originating program has tested it in either setting.

🧪 Theoretical / mechanistic

🧬 Vitamin A

Required for thyroid hormone receptor binding at the nucleus.

✅ Clinically validated⚠ Safety flag

🧬 Guggul

Increases T4→T3 conversion in rodents; weak human data and many drug interactions.

🧪 Theoretical / mechanistic

🧬 Ashwagandha

Raised T4 and T3 in a small randomized trial in subclinical hypothyroidism — with the caveat that this makes it a poor idea in hyperthyroidism.

✅ Clinically validated

💉 GC-1

A thyroid-β-selective agonist designed to raise metabolic rate without cardiac effects. Mechanistically elegant, no human fatigue data.

🧪 Theoretical / mechanistic⚠ Safety flag
Nothing here is ranked by evidence tier. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for. The tier is a label. The mechanism is the map.

What actually decides this outcome, in order of size

Thyroid hormone is made in one place, converted in another and read in a third, and the standard screening test only sees the feedback from the first. Ranked by how much of the outcome each one owns:

  1. Whether the gland is failing or the conversion is, because they look identical from the outside and respond to different things. TSH (Thyroid-Stimulating Hormone) reports pituitary feedback, Free T4 (Thyroxine) reports output, and Free T3 (Triiodothyronine) reports what conversion produced. Testing the first alone misses impaired conversion entirely, which is the specific failure this pathway exists for.
  2. Whether it is autoimmune, because that changes both the prognosis and what is safe to take. Thyroid antibodies at population scale were characterized in a national survey Hollowell 2002, and selenium reduced thyroid peroxidase antibodies in autoimmune thyroiditis Gartner 2002. In autoimmune disease high-dose iodine can make things considerably worse, which turns a common supplement into a hazard.
  3. Whether the test itself is lying, which happens in at least two documented ways. Macro-TSH is a complexed form that inflates the result; polyethylene glycol precipitation to detect it has been reviewed systematically Piticchio 2024 and its prevalence in subclinical hypothyroidism has been characterized Nishihara 2026. Anti-TSH autoantibodies interfere with clinical detection directly Tang 2024. And raised thyroid hormones with a non-suppressed TSH has its own diagnostic approach Moran 2023. A single odd result is a reason to repeat and to ask the laboratory, not a diagnosis.
  4. Whether treating a mildly abnormal result helps, which has actually been tested. Thyroid hormone therapy for older adults with subclinical hypothyroidism was studied in a randomized trial Stott 2017. That result is the reason this pathway does not treat a borderline number as an automatic prescription, and it is the clearest surrogate-versus-outcome finding in the energy estate.
  5. The cofactors, because conversion is enzymatic and the enzymes need specific minerals. The deiodinases are selenoproteins; thyroid peroxidase is iron-dependent, so low Ferritin impairs synthesis before it causes anemia; and iodine is the substrate, with sufficiency mattering particularly around fertility and gestation Feldt-Rasmussen 2025. Selenium with coenzyme Q10 has cardiovascular mortality data in an elderly population with low selenium status Alehagen 2013, which is a repletion result rather than a thyroid one.
  6. The compounds, last, and one of them is only appropriate in one direction. Ashwagandha raised T4 and T3 in a small randomized trial in subclinical hypothyroidism Sharma 2018, which makes it actively unhelpful in the opposite situation. Brown adipose activation on liothyronine has been imaged Bjerkreim 2021, which is mechanistically interesting and is not a fatigue endpoint.

The order to run these in, and what has to be true first

Test all three levels, exclude the interferences, correct the cofactors, and only then discuss a prescription. The order is set by the fact that a wrong number here leads to a treatment that is hard to reverse.

  1. The full panel, not just the screening test. TSH (Thyroid-Stimulating Hormone), Free T4 (Thyroxine), Free T3 (Triiodothyronine), Thyroid Antibodies (TPO + TgAb) with Thyroglobulin Antibody, and Ferritin on the same requisition. Add Reverse T3 only if you already know how you intend to interpret it, because it rises in any illness or energy deficit and is over-read constantly.
  2. Repeat an abnormal result before acting on it, and ask about interference if the picture is internally inconsistent. Macro-TSH and anti-TSH antibodies both distort the number Piticchio 2024 Tang 2024, and raised hormones with a non-suppressed TSH has a defined approach Moran 2023. Biotin at supplement doses interferes with many of these assays and is the commonest reversible cause of a bizarre panel.
  3. Correct iron, selenium and iodine status before concluding anything about conversion. Ferritin, Selenium, Blood and Iodine. Iron affects synthesis, selenium affects conversion Gartner 2002, and iodine is the substrate with a real upper limit Feldt-Rasmussen 2025. Iodine is the one where more is actively dangerous in autoimmune disease.
  4. Selenium next if antibodies are positive, and measure it. The antibody reduction is established Gartner 2002 and the window between sufficiency and toxicity is narrow. The cardiovascular mortality result with coenzyme Q10 was in a population with low baseline status Alehagen 2013, which is the pattern for almost every mineral on this pathway.
  5. Zinc, Vitamin A and L-Tyrosine are the remaining cofactor and substrate arguments and belong here rather than higher. Zinc is required for conversion and receptor function, vitamin A for receptor binding at the nucleus, and tyrosine is the backbone. All three are corrections, and none of them does anything in somebody already replete.
  6. Ashwagandha only where the direction is hypothyroid. The randomized evidence is in subclinical hypothyroidism Sharma 2018, and the same effect is a reason to avoid it in hyperthyroidism.
  7. A prescription is a clinical decision and the borderline case is genuinely contested. The randomized trial in older adults with subclinical hypothyroidism is the document that conversation should start from Stott 2017, and Thyreogen is not an answer to a panel that says hypothyroid.
  8. GC-1 and Guggul are the research and traditional ends respectively. A beta-selective thyroid agonist designed to raise metabolic rate without cardiac effects is mechanistically elegant with no human fatigue data; guggul raises conversion in rodents and carries many drug interactions.

What gets bought for this that cannot move it

The category that fails structurally is the thyroid support blend bought against a normal panel. Cofactor blends act on conversion, and conversion is only the bottleneck in some people. A blend given to somebody whose gland is failing does nothing while delaying the prescription that would have worked, and a blend given to somebody with a normal panel is repletion of the already-replete. This is the pathway where the requisition is not optional.

The surrogate here is TSH, and it fails in three separate directions. It is a pituitary feedback signal rather than a tissue measurement, so it misses impaired conversion. It is distorted by macro-TSH Piticchio 2024 Nishihara 2026 and by anti-TSH autoantibodies Tang 2024, which are laboratory artifacts rather than physiology. And when it is mildly abnormal, treating it did not produce the benefit people assume in a randomized trial Stott 2017. Three different failure modes in one number, and it is the number almost every reader arrives with.

Reverse T3 is the second surrogate and it is over-interpreted. It rises in acute illness, sustained energy restriction and any catabolic state, which means it is usually reporting that the body is conserving rather than that a supplement is needed. Treating a high reverse T3 in somebody in a deficit is treating the adaptation.

If the goal underneath is different, so is the page. If fatigue comes with a flattened stress curve rather than cold intolerance, Adrenal, cortisol rhythm & stress-driven fatigue. If the panel is normal and fatigue persists, Oxygen carrying, blood sugar & the boring causes and Mitochondrial ATP production. If the target is resting metabolic rate during weight loss, Thyroid & thermogenic substrate. And palpitations, tremor, heat intolerance and weight loss are hyperthyroidism, which is an urgent assessment and the exact situation where several items on this page make things worse.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. Free T3 (Triiodothyronine) with Free T4 (Thyroxine) will separate a conversion problem from a production problem where TSH (Thyroid-Stimulating Hormone) alone cannot; and on any levothyroxine dose change nothing is interpretable before six weeks, because the hormone's circulating half-life sets the equilibration time and no cofactor shortens it.

What will fool you. Biotin at supplement doses interferes with many thyroid immunoassays and can produce a picture that looks like Graves disease; stop it for several days before drawing. TSH has a diurnal rhythm and is higher in the early morning, so a draw time change is a result change. Any acute illness lowers T3 and raises reverse T3 as an adaptation. Macro-TSH and anti-TSH antibodies both inflate the number Nishihara 2026 Tang 2024. And an energy deficit lowers T3 on purpose, so a panel drawn mid-diet is describing the diet.

Sources read for these sections

  • Hollowell JG, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994). Journal of Clinical Endocrinology and Metabolism 2002 · PMID 11836274
  • Stott DJ, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. New England Journal of Medicine 2017 · PMID 28402245
  • Sharma AK, et al. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. The Journal of Alternative and Complementary Medicine, 2018 · PMID 28829155
  • Gartner R, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology and Metabolism 2002;87(4):1687-1691 · PMID 11932302
  • Feldt-Rasmussen U. Importance of iodide sufficiency and normal thyroid function in fertility and during gestation. Thyroid Research 2025 · PMID 40420166
  • Moran C, et al. Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH. Journal of Clinical Endocrinology and Metabolism 2023 · PMID 37988295
  • Piticchio T, et al. PEG Precipitation to Detect Macro-TSH in Clinical Practice: A Systematic Review. Clinical Endocrinology 2024 · PMID 39702982
  • Nishihara E, et al. Prevalence and Clinical Characteristics of Macro-TSH in Patients with Subclinical Hypothyroidism. Thyroid 2026 · PMID 42236450
  • Tang M, et al. The interference of anti-TSH autoantibody on clinical TSH detection. Frontiers in Endocrinology 2024 · PMID 38978630
  • Bjerkreim BA. Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study. Frontiers in Endocrinology (Lausanne) 2021 · PMID 34867829
  • Alehagen U, et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. International Journal of Cardiology, 2013 · PMID 22626835

The other 3 routes to energy & fatigue

Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.

You know the goal. Skool has the plan.

This pathway is one arm of The Energy & fatigue Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.

Open The Energy & fatigue Blueprint in Skool →

$10/mo, cancel anytime.

← Open this pathway in the interactive Vault

Frequently asked questions

What is the thyroid & metabolic rate pathway for energy & fatigue?

Thyroid hormone sets the pace of every cell. Hypothyroid fatigue comes with cold intolerance, constipation, dry skin and weight gain — and the common failure is testing TSH alone, which misses impaired T4→T3 conversion entirely.

What compounds and supplements work through thyroid & metabolic rate?

11 options are mapped to this pathway in the Vault, including Selenium, Iodine, Zinc, Iron. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 6 carry clinical validation and 5 are mechanistic predictions.

How do I know if thyroid & metabolic rate is actually my problem?

TSH alone is not a thyroid panel. Normal TSH with low free T3 is impaired conversion, and it is the single most common thing missed in fatigue — you need the full set to see it. The markers worth checking are TSH (Thyroid-Stimulating Hormone), Free T3 (Triiodothyronine), Free T4 (Thyroxine), Reverse T3.

Are the 5 theoretical options for thyroid & metabolic rate worth considering?

Unproven is not the same as ineffective. Of the 11 options on this pathway, 6 have clinical validation and 5 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.

Where this goes next

The full protocol$10/mo

Everything above is the free case for Thyroid & metabolic rate. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.

Educational and research reference only — not medical advice, and not a recommendation for human use. Mechanistic predictions are exactly that: what the biology suggests should happen, which is not the same as what has been shown to happen.

↑ Back to on this page

The blueprint this pathway sits insideThe Energy & Fatigue Blueprint →The full 12-week stack this pathway belongs to — every arm, the sequence, and the bloodwork.